Germline mutation of ARF in a melanoma kindred

Human Molecular Genetics

Volumn 11, Issue 11, 2002, Pages 1273-1279

  Hewitt, Chelsee ^a   Wu, Chu Lee ^a   Evans, Gareth ^a   Howell, A ^b   Elles, Robert G ^a   Jordan, Richard ^c   Sloan, Philip ^d   Read, Andrew P ^a   Thakker, Nalin ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b CHRISTIE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY DENTAL HOSPITAL OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARF PROTEIN; RETINOBLASTOMA PROTEIN; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; BASE PAIRING; BREAST CANCER; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CASE REPORT; CONTROLLED STUDY; EXON; FAMILY; FEMALE; GENE DELETION; GENE INSERTION; GENE LOCUS; GENE MUTATION; GENETIC CODE; GENETIC PREDISPOSITION; GENETIC TRANSCRIPTION; GERM LINE; HAPLOIDY; HETEROZYGOSITY LOSS; HUMAN; KNOCKOUT MOUSE; MELANOMA; PHENOTYPE; PRIORITY JOURNAL; RNA SPLICING; TUMOR SUPPRESSOR GENE;

INSERTION SEQUENCES;

EID: 0037093319     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/11.11.1273     Document Type: Article

References (37)

1. Compilation of somatic mutations of the CDKN2 gene in human cancers: Non-random distribution of base substitutions
2. Germline CDKN2A mutations in familial melanoma
3. Splicing into senescence: The curious case of CDKN2A and p19ARF
4. The retinoblastoma protein and cell cycle control
5. Signaling to p53: Breaking the MDM2-p53 circuit
6. The Pezcoller lecture: Cancer cell cycles revisited
7. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF
8. Functional evidence for a role combined CDKN2A (p16-p14(ARF)/CDKN2B (p15) gene inactivation in malignant gliomas
9. Adenovirus-mediated p14 (ARF) gene transfer in human mesothelioma cells
10. MDM2-master regulator of the p53 tumor suppressor protein
11. Interaction between the retinoblastoma protein and the oncoprotein MDM2
12. The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53
13. Inactivations of p16INK4a-alpha, p16INK4a-beta and p15INK4b genes in 2′,3′-dideoxycytidine- and 1,3-butadiene-induced murine lymphomas
14. Methylation of the 5′ CpG island of the CDKN2A/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing
15. 5′ CpG island methylation is associated with transcriptional silencing of the tumor suppressor CDKN2A/CDKN2/MTS1 in human cancers
16. Frequency of homozygous deletion at CDKN2A/CDKN2 in primary human tumors
17. Functional analysis of wild-type and malignant glioma derived CDKN2Abeta alleles: Evidence for an RB-independent growth suppressive pathway
18. DNA studies underestimate the major role of CDKN2A inactivation in oral and oropharyngeal squamous cell carcinomas
19. Genomic alterations of the p19ARF encoding exons in T-cell acute lymphoblastic leukemia
20. Selective deletion of exon 1beta of the p19ARF gene in metastatic melanoma cell lines
21. The human p19ARF protein encoded by the beta transcript of the p16INK4a gene is frequently lost in small cell lung cancer
22. Expression of p16INK4a/p16alpha and p19ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpression
23. Germline mutations in the p16(INK4a) binding domain of CDK4 in familial melanoma
24. Prevalence of germ-line mutations in p16, p19ARF, and CDK4 in familial melanoma: Analysis of a clinic-based population
25. Affected members of melanoma-prone families with linkage to 9p21 but lacking mutations in CDKN2A do not harbor mutations in the coding regions of either CDKN2B or p19ARF
26. CDKN2a/p16INK4a mutations and lack of p19ARF involvement in familial melanoma kindreds
27. A germline deletion of p14(ARF) but not CDKN2A in a melanoma-neural system tumour syndrome family
28. A melanoma associated germline mutation in exon 1β inactivates p14ARF
29. The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: Causes and consequences
30. Comparison of nonfamilial and familial melanoma
31. CDKN2A germline splicing mutation affecting both p16(ink4) and p14(arf) RNA processing in a melanoma/neurofibroma kindred
32. Mutations in the INK4a/ARF melanoma susceptibility locus functionally impair p14ARF
33. Ink4a confers susceptibility to metastatic melanoma in mice
34. Alleles of APC modulate the frequency and classes of mutations that lead to colon polyps
35. The type of somatic mutation at APC in familial adenomatous polyposis is determined by the site of the germline mutation: A new facet to Knudson's 'two-hit' hypothesis
36. Dual inactivation of RB and p53 pathways in RAS-induced melanomas
37. Germ-line deletion involving the INK4 locus in familial proneness to melanoma and nervous system tumors